Evidence map›Paper›PMID 22679001›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2012

Cytosolic sulfotransferase 2B1b promotes hepatocyte proliferation gene expression in vivo and in vitro.

Xin Zhang, Qianming Bai, Leyuan Xu, Genta Kakiyama, William M Pandak, Zhigang Zhang, Shunlin Ren

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Cholestenoic acid as endogenous epigenetic regulator decreases hepatocyte lipid accumulation in vitro and in vivo.American journal of physiology. Gastrointestinal and liver physiology · 2024
    Article
  2. Human sulfotransferaseFrontiers in genetics · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. IntestinalBioMed research international · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Xin ZhangDepartment of Pathology, Fudan University Shanghai Medical College, Shanghai, China.
Qianming Bai
Leyuan Xu
Genta Kakiyama
William M Pandak
Zhigang Zhang
Shunlin Ren
Shanghai Medical College of Fudan University · CNVirginia Commonwealth University · USHunter Holmes McGuire VA Medical Center · US

Funding

REGULATION OF CHOLESTEROL METABOLISMR01HL078898 · NHLBI · RICHMOND INSTITUTE FOR VETERANS RESEARCH · PI REN, SHUNLIN · 2006 to 2010
$1.5M
Novel Regulatory Pathway in Prevention of AtherosclerosisI01BX001874 · VA · VA VETERANS ADMINISTRATION HOSPITAL · PI REN, SHUNLIN · 2013 to 2016
–
BLRD VA I01 BX000197BLRD VA I01 BX001874NHLBI NIH HHS R01 HL-078898
6 · The paper itself

Abstract

Cytosolic sulfotransferase 2B1b (SULT2B1b) catalyzes the sulfation of 3β-hydroxysteroids and functions as a selective cholesterol and oxysterol sulfotransferase. Activation of liver X receptors (LXRs) by oxysterols has been known to be an antiproliferative factor. Overexpression of SULT2B1b impairs LXR's response to oxysterols, by which it regulates lipid metabolism. The aim of this study was to investigate in vivo and in vitro effects of SULT2B1b on liver proliferation and the underlying mechanisms. Primary rat hepatocytes and C57BL/6 mice were infected with adenovirus encoding SULT2B1b. Liver proliferation was determined by measuring the proliferating cell nuclear antigen (PCNA) immunostaining labeling index. The correlation between SULT2B1b and PCNA expression in mouse liver tissues was determined by double immunofluorescence. Gene expressions were evaluated by quantitative real-time PCR and Western blot analysis. SULT2B1b overexpression in mouse liver tissues increased PCNA-positive cells in a dose- and time-dependent manner. The increased expression of PCNA in mouse liver tissues was only observed in the SULT2B1b transgenic cells. Small interference RNA SULT2B1b significantly inhibited cell cycle regulatory gene expressions in primary rat hepatocytes. LXR activation by T0901317 effectively suppressed SULT2B1b-induced gene expression in vivo and in vitro. SULT2B1b may promote hepatocyte proliferation by inactivating oxysterol/LXR signaling.

Indexed as

AdenoviridaeAnimalsCell ProliferationCytosolGene ExpressionHepatocytesLiver X ReceptorsMiceOrphan Nuclear ReceptorsProliferating Cell Nuclear AntigenRatsRNA, MessengerSignal TransductionSulfotransferasesLiver X ReceptorsOrphan Nuclear ReceptorsProliferating Cell Nuclear AntigenRNA, MessengerSulfotransferasesSULT2B1b protein, mouse

Identifiers

PMID22679001
PMCPMC3423104
OpenAlexW2007398459

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.